(Q40872189)

24 September 2017

1 reference

title

Neurobiological models of obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

24 September 2017

1 reference

Rauch SL

1

1 reference

PubMed ID

8426888

24 September 2017

Jenike MA

series ordinal

2

1 reference

24 September 2017

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

34

1 reference

24 September 2017

1

1 reference

24 September 2017

20-32

1 reference

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Neuroanatomy of Gilles de la Tourette's Syndrome Possible Midbrain Involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Clinical comparison of Tourette's disorder and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Animal models of compulsive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Brain MRI in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

A compulsive movement disorder with cavitation of caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Transient feelings of compulsion caused by hemispheric lesions: three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Nuclear magnetic resonance study of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Cerebral glucose metabolic rates in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessive-compulsive disorder: is there a frontal lobe dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Signs of central nervous system dysfunction in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Endogenous event-related potentials in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Stereotactic radiofrequency thermal cingulotomy for obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Reward-induced stereotypy: modulation by the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

The cingulate gyrus and human behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Stereotactic Limbic Leucotomy—A Follow-up at 16 Months

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Modified leukotomy in the treatment of intractable obessional neurosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Survey of nine years of lobotomy investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Interictal behaviour in hospitalised temporal lobe epileptics: relationship to idiopathic psychiatric syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Neurological factors in obsessive compulsive disorder. Two case reports and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

The electroencephalogram and personality organization in the obsessive-compulsive reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Carbamazepine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Fluvoxamine treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Open trial of fluoxetine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessive-compulsive disorder and serotonin: is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

A Double Blind Study of Imipramine versus Zimelidine in Treatment of Obsessive Compulsive Neurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Lactate infusions in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Effects of yohimbine in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

An open trial of buspirone in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Cognitive deficits in compulsive checkers: an exploratory study.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Cognitive dysfunction in compulsive checkers: further explorations.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Obsessional personality disorder and remembering

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Pimozide in the treatment of monosymptomatic hypochondriacal psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971924-6

7 January 2021

10.1016/S0033-3182(93)71924-6

Identifiers

DOI

0 references

PubMed ID

8426888

1 reference

PubMed ID

8426888